Brought to you by 
Inhale Therapeutics acquires Shearwater
01 Aug 2001
Executive Summary
Pulmonary drug delivery company Inhale Therapeutic Systems has acquired privately held Shearwater (PEGylation drug delivery technology) for $191.7mm--$72.5mm in cash and 4mm shares of stock, worth 119.2mm (based on Inhale's average trading price).
Deal Industry
- Biotechnology
- Pharmaceuticals
-
Pharmaceuticals
-
Drug Delivery
- Macromolecule
-
Drug Delivery
-
Biotechnology
- Large Molecule
Deal Status
- Final
Deal Type
-
Acquisition
- Full Acquisition
- Includes Contract
- Payment Includes Cash
- Payment Includes Stock
Already a Biomedtracker subscriber?
You have access to the full deal record through your subscription
Want to become a subscriber?
Subscribers get more deal details, updates, deal financials and deal products.
Questions?
Questions?
Please contact Sales at: (212) 520-2765 or email PharmaNewsSales@informa.com